CD Protein Inhibitors  >>  Phase 2


1234567891011»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 07142128354249566370
            
            
             
alvocidib (DSP-2033) / Sumitomo Pharma           
          
            
             
siplizumab (TCD601) / ITBMed           
          
            
             
Tecartus (brexucabtagene autoleucel) / Gilead           
          
            
             
VRC01 / Acuitas Therap           
          
            
             
ETBX-011 / ImmunityBio           
          
            
             
urelumab (BMS-663513) / BMS, Ono Pharma           
          
            
             
Cavatak (gebasaxturev) / Merck (MSD)           
          
            
             
Elzonris (tagraxofusp-erzs) / Menarini, Nippon Shinyaku           
          
            
             
LymphoCide Y-90 (epratuzumab Y-90) / Gilead           
          
            
             
MK-4830 / Merck (MSD)           
          
            
             
Orthoclone OKT3 (muromonab-CD3) / J&J           
          
            
             
sotigalimab (PYX-107) / Pyxis Oncology           
          
            
             
varlilumab (CDX 1127) / Celldex           
          
            
             
GI-6207 / BMS           
          
            
             
pidilizumab (CT-011) / CureTech           
          
            
             
tobemstomig (RG6139) / Roche           
          
            
             
pepinemab (VX15) / Vaccinex           
          
            
             
GC012F / AstraZeneca           
          
            
             
iscalimab (CFZ533) / Novartis           
          
            
             
SDS-19CAR / Innovative Cellular Therapeutics           
          
            
             
Yuanruida (inaticabtagene autoleucel) / CASI, Juventas Cell Therapy           
          
            
             
ligufalimab (AK117) / Akesobio           
          
            
             
quemliclustat (AB680) / Arcus Biosci, Gilead           
          
            
             
Aibining (geptanolimab) / Apollomics           
          
            
             
CDX-1140 / Celldex           
          
            
             
T3011 / ImmVira Pharma           
          
            
             
TT11 / Tessa Therap, UNC Lineberger Comprehensive Cancer Center, Baylor Scott & White Research Institute           
          
            
             
daxdilimab (HZN-7734) / Amgen           
          
            
             
INCB99280 / Incyte           
          
            
             
Veltucyn (veltuzumab) / Gilead           
          
            
             
atibuclimab (IC14) / Implicit Biosci           
          
            
             
danvilostomig (SI-B003) / Biokin Pharma           
          
            
             
pCAR-19B / Chongqing Precision Biotech           
          
            
             
rhIL-15 / National Cancer Institute           
          
            
             
ADG106 / Adagene           
          
            
             
C-CAR011 / Cellular Biomedicine           
          
            
             
IM19 CAR-T cells / Beijing Imunopharm, Simcere           
          
            
             
IMC-001 / Sorrento, Immuneoncia Therap           
          
            
             
TQB2858 / Sino Biopharm           
          
            
             
ThisCART19A / Fundamenta Therap           
          
            
             
cusatuzumab (ARGX-110) / OncoVerity           
          
            
             
dacetuzumab (SGN-40) / Pfizer           
          
            
             
maplirpacept (TTI-622) / Pfizer           
          
            
             
tegoprubart (AT-1501) / Eledon           
          
            
             
tomivosertib (eFT508) / eFFECTOR Therap           
          
            
             
vudalimab (XmAb717) / Xencor           
          
            
             
Actimab-A (lintuzumab-Ac225) / Actinium           
          
            
             
BI 764532 / Boehringer Ingelheim           
          
            
             
C-13-60 / Chongqing Precision Biotech           
          
            
             
KYV-101 / Kyverna           
          
            
            


1234567891011»